Sarepta Therapeutics (SRPT) – General News
-
US FDA approves Sarepta's gene therapy for rare muscular dystrophy in some kids
-
Midday movers: Activision Blizzard, Oneok, Newmont and more
-
Sarepta surges after FDA panel backs Duchenne gene therapy
-
Midday movers: Delta Air Lines, Harley Davidson, Rent the Runway and more
-
Sarepta shares drop as report says FDA almost rejected under-review gene therapy
-
Biogen plunges 30% after FDA panel votes against Alzheimer's drug
-
Sarepta shares fall 4% after FDA documents show safety concerns about drug
-
Sarepta shares surge after surprise approval of Duchenne Muscular Dystrophy drug
-
Sarepta surges after Pfizer gene therapy data raises safety concerns
-
Mali reported its first case of Ebola in a 2-year old girl
-
Video Shows Upbeat Ebola Nurse Nina Pham
-
CDC Expands Notification Following Recent Flight by Second U.S. Ebola Patient (CMRX) (TKMR) (VSR)
-
U.S. Ebola Outbreak Containment in Question as 2nd Nurse Contracts Disease, Travels to Cleveland
-
Second Healthcare Worker Tests Positive for Ebola in Texas (CMRX) (LAKE) (NLNK) (APT)
-
CDC confirms first Ebola case diagnosed in the U.S. (TKMR)
-
UPDATE: Doctor, Nurse Treated with ZMapp Show Marked Improvement - Bloomberg Citing WHO
-
WHO Updates on Ebola Outbreak for Aug. 12th - 13th: 76 Deaths Reported
-
52 Ebola Deaths Reported from August 7-9, Says WHO
Back to SRPT Stock Lookup
